ืขืืจืืช,ย Spanish โ Espaรฑol,ย ะ ัััะบะธะน,ย Deutsch,ย English, ๆฅๆฌ่ช.

ๆ ขๆง่ ่็ ใฏไธ่ฌใซๆฉ่ฝไฝไธใฎ้ฒ่กใจใใฆ็่งฃใใใพใใใ่ฟๅนดใฎ็ ็ฉถใงใฏใ็ไฝๅ ใฎ่ชฟ็ฏใป็ถญๆๆฉๆงใ้่ฆใชๅฝนๅฒใๆใใใใจใ็คบๅใใใฆใใพใใ
ๆฌ็จฟใงใฏใใจใใซใฎใผไปฃ่ฌใ็ดฐ่ไฟ่ญทใจใฏใชใขใฉใณในใ่กๆตใจๅ จ่บซ็ฐๅขใจใใไธใคใฎ่ปธใใใ่ ๆฉ่ฝใๆฏใใใกใซใใบใ ใๆด็ใใพใใ
๏ผโป ็ไฝใฎๅ ๅจ็ใช่ชฟ็ฏๆฉๆงใซ็็ฎใใๆฆๅฟตใขใใซ๏ผ
The following table summarizes key biological pathways discussed in the literature.
๐ Table: Key Biological Pathways in Kidney Function and Their Potential Modulation
| Pathway | Primary Role in Kidney Function | Potential Modulation (Natural Interventions) | Additional Organs Affected |
|---|---|---|---|
| AMPK โ SIRT1 โ PGC-1ฮฑ | Mitochondrial biogenesis; protection of podocytes and tubular cells | Resveratrol; light physical activity (e.g., walking); intermittent fasting | Heart, brain, liver, lungs |
| Nrf2โKeap1 | Antioxidant defense; detoxification; inflammation reduction | Sulforaphane (broccoli sprouts); curcumin | Gut barrier, liver, heart, brain, lungs |
| Mitophagy / Autophagy + TFEB | Removal of damaged mitochondria and cellular debris | Urolithin A (pomegranate derivatives); resveratrol; sulforaphane | Liver, heart, brain, lungs, gut |
| FGF23โKlotho | Phosphateโcalcium balance; anti-fibrotic; anti-aging effects | Vitamin D3 (controlled dosing); resveratrol; sulforaphane; physical activity | Heart (reduced calcification), brain, lungs |
| GutโKidney Axis | Reduction of systemic inflammation; decreased toxin load (e.g., TMAO); gut barrier support | Sulforaphane; urolithin A; targeted probiotics | Gut, liver, heart, brain, lungs |
| HPT Axis (Thyroid) | Regulation of metabolic rate and mitochondrial activity (T3) | Resveratrol; sulforaphane; physical activity | Heart, brain, liver, lungs |
| mTORC1 | Regulation of cellular growth; chronic overactivation linked to fibrosis | Mild inhibition via AMPK activation (resveratrol; sulforaphane) | Heart, liver, skeletal muscle |
| Wnt/ฮฒ-catenin | Chronic activation linked to fibrosis and podocyte injury | Resveratrol; curcumin; sulforaphane | Heart, liver, lungs, brain |
| NO / eNOS | Vascular dilation; improved renal blood flow; endothelial protection | Polyphenols (e.g., resveratrol); plant-derived compounds (e.g., Opuntia ficus-indica) | Heart, brain, lungs, liver, gut |
| Irisin / FNDC5 | Myokine-mediated protection of kidney cells; podocyte support | Physical activity; PGC-1ฮฑ activation | Brain (BDNF), heart, liver, lungs |
| PPARฮฑ | Fatty acid oxidation in renal cells; prevention of lipotoxicity | Resveratrol; sulforaphane; physical activity | Liver, heart, brain |
| Epigenetic Regulation | Long-term gene expression modulation; cellular memory | SIRT1 activation (resveratrol); sulforaphane; physical activity | System-wide |
| Vitamin D / VDR | Direct activation of Klotho; podocyte protection; anti-inflammatory effects | Vitamin D3 (monitored dosing); controlled sun exposure | Brain, heart, lungs, gut, bone |
ๆฌ่กจใฏๆ่ฒ็ใปๆฆๅฟต็ใชๆด็ใ็ฎ็ใจใใฆใใใ็นๅฎใฎๆฒป็ใๆจๅฅจใใใใฎใงใฏใใใพใใใ
ืขืืจืืช, Spanish โ Espaรฑol, ะ ัััะบะธะน, Deutsch, English
๐ ๅ่ๆ็ฎ๏ผReferences๏ผ
๐ ใจใใซใฎใผไปฃ่ฌใจๅ็๏ผEnergy and Regeneration๏ผ
- Hallan S, Sharma K. The role of mitochondria in diabetic kidney disease. Nat Rev Nephrol.
- Bhargava P, Schnellmann RG. Mitochondrial energetics in the kidney. Nat Rev Nephrol.
- Hardie DG. AMPK: a key regulator of energy balance in the kidney. Physiol Rev.
- Cantรณ C, Auwerx J. Targeting sirtuin 1 to improve metabolism. Nat Rev Drug Discov.
- Hasegawa K et al. SIRT1 protects against oxidative stress in kidney disease. J Am Soc Nephrol.
- Scarpulla RC. PGC-1ฮฑ and mitochondrial biogenesis. Cell Metab.
- Kume S et al. Role of nutrient-sensing pathways in diabetic nephropathy. J Am Soc Nephrol.
- Martins R et al. FOXO proteins and aging. Aging Cell.
- Cheng Z et al. SIRT1/FOXO pathway in renal protection. Kidney Int.
- Verdin E. NADโบ metabolism and aging. Science.
๐ก๏ธ ็ดฐ่ไฟ่ญทใจใฏใชใขใฉใณใน๏ผProtection and Clearance๏ผ
- Yamamoto M et al. The KEAP1โNRF2 system: a master regulator of oxidative stress. Physiol Rev.
- Ruiz S et al. Targeting the Nrf2 pathway in kidney disease. Kidney Int.
- Ding Y, Choi ME. Autophagy in diabetic nephropathy. J Endocrinol.
- Livingston MJ et al. Autophagy in acute kidney injury and repair. J Clin Invest.
- Kimura T et al. Autophagy and the kidney. Nat Rev Nephrol.
- Pickles S et al. Mitophagy and mitochondrial quality control. Nat Rev Mol Cell Biol.
- Settembre C et al. TFEB links autophagy to lysosomal biogenesis. Science.
- Mizushima N. Autophagy: process and function. Genes Dev.
๐ ็ฐๅขใป่กๆตใปๅ จ่บซ็ธไบไฝ็จ๏ผEnvironment, Flow, and Systemic Interaction๏ผ
- Fรถrstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J.
- Vanhoutte PM et al. Endothelial dysfunction and vascular disease. Acta Physiol.
- Crowley SD, Coffman TM. The inextricable role of the kidney in hypertension. J Clin Invest.
- Mezzano SA et al. Renin-angiotensin system and renal fibrosis. Kidney Int Suppl.
- Fine LG, Norman JT. Chronic hypoxia as a mechanism of kidney disease progression. Kidney Int.
- Haase VH. Hypoxia-inducible factors in kidney disease. J Am Soc Nephrol.
- Ruiz-Ortega M et al. TGF-ฮฒ signaling in renal fibrosis. Nat Rev Nephrol.
- Evenepoel P et al. The gut-kidney axis. Nat Rev Nephrol.
- Vaziri ND et al. CKD alters gut microbiome and toxin generation. Kidney Int.
- Tang WHW et al. Gut microbiota and cardiovascular disease (TMAO pathway). N Engl J Med.
๐น ๆ ขๆง่ ็พๆฃใใใณ็ท็ถญๅใซ้ขใใ่ฃ่ถณๆ็ฎ๏ผCKD and Fibrosis๏ผ
- Kalantar-Zadeh K et al. Chronic kidney disease. Lancet.
- Levin A et al. Kidney disease: global burden and management. Lancet.
- Ruiz S, Pergola PE, Zager RA. Targeting oxidative stress in CKD. Kidney Int.
- Nath KA. Tubulointerstitial changes as a major determinant in CKD. Kidney Int.
- Friedman SL et al. Mechanisms of fibrosis across organs. J Clin Invest.
ใ่ณชๅใฏใใใพใใ๏ผ
ไปฅไธใฎ้ฃ็ตกๅ ใ้ใใฆใใคใญใณใปใใซใดใชใณใซใๅใๅใใใใ ใใใ
ใๆณจๆใใ ใใ๏ผ
ใ่ช่บซใใพใใฏใๅฎถๆใฎๅฅๅบท็ถๆ ใซ้ข้ฃใใใในใฆใฎ่ฃฝๅ๏ผ้ฃๅใๆฝๅบ็ฉใใตใใชใกใณใใใฏใชใผใ ใ้ๅใชใฉ๏ผใใไฝฟ็จใซใชใๅใซใๅฟ ใไฟก้ ผใงใใๅปๅธซใพใใฏ่ฌๅคๅธซใซใ็ธ่ซใใ ใใใ

่ๅฐใใๅผ้ๅพใฏใๆ ขๆง็พๆฃใ็นใซ่ ๆฉ่ฝใซ้ขใใๅฎ่ทต็ใชๅใ็ตใฟใซ้ขใใใใใซใชใใ่บซไฝใซๆฌๆฅๅใใ่ชฟ็ฏใปๅๅพฉใกใซใใบใ ใซ็็ฎใใ่ฆ็นใ็บๅฑใใใฆใใพใใใ
ๅฝผใฎใขใใญใผใใฏใๅพๆฅใฎๆฒป็ใ็ฝฎใๆใใใใฎใงใฏใชใใ็ไฝๅ ใฎ็ถญๆใป่ชฟๆดๆฉๆงใ็่งฃใใใใใฎ่ฃๅฎ็ใชๆ ็ตใฟใจใใฆไฝ็ฝฎใฅใใใใฆใใพใใ
ๅฝผใฎใฆใงใใตใคใ๏ผYARONMARGOLIN.COM๏ผใใใงใคในใใใฏใใผใธใ็ใใฎๅงๆณใใๆฌ่จไบใใใใณใใฎไปใฎ่ซๆใซ่จ่ผใใใฆใใๆ ๅ ฑใฏใใ่ๅฏใฎใใใฎๅฒๅญฆ็่ณๆใใงใใใๅป็ไธใฎๆจๅฅจใๆๅฐใงใฏใใใพใใใ
ใใฎใตใคใใใพใใฏ้ข้ฃใใใในใฆใฎ่ณๆใฏใๅฆๆน่ฌใฎไฝฟ็จใพใใฏไธญๆญขใซ้ขใใไปฃๆฟใจใชใใใฎใงใฏใชใใๅฅๅบทใซ้ขใใฆๆฑบๅฎใ่กใใใใฎๅฏไธใฎๆ ๅ ฑๆบใจใในใใงใฏใใใพใใใ
ไธ่ชฟใ็ใฟใไฝฟ็จ็ฎ็ใซ้ขใใฆใฏใๅธธใซ่ณๆ ผใฎใใๅฐ้ๅปใพใใฏ่ฌๅคๅธซใจ็ธ่ซใใฆใใ ใใใ
ใใฎใใผใใซ้ขใใใคใญใณใปใใผใดใชใณใซใใใใใฉใค่ชใจ่ฑ่ชใฎ่จไบ
ืืืจืื ืื
- ๐ฏ๐ต ่ ๆฉ่ฝใจๅ จ่บซใฎๅฅๅบทใซ้ขใใ็ไฝ่ชฟ็ฏใกใซใใบใ ใฎ
- ใคใญใณใปใใซใดใชใณใฎๆฒป็ใฎๅบๆฌๅๅ
- ๐ฌ๐ง Understanding Intrinsic Regulatory Mechanisms:
- Kรถrpereigene Regulationsmechanismen verstehen: Bedeutung fรผr Nieren, Herz, Gehirn und weitere Organsysteme
- ๐ ะะฐััะฐ ะฟััะตะน ะฒะพัััะฐะฝะพะฒะปะตะฝะธั
- Mapa de las Vรญas de Recuperaciรณn
- ืืืืืื ืชื ืืขื โ ืืชืงืืื ืืืืฉื ืืืืื ืืืืืช: ืชืจืืืืืช ืฉืืืงืืช ืืช ืฆืืจื ืืืืืื ืฉื ืคืขืืืืช ืืืคื ืืช
- ืืืืฃ ืืืืข ืขื ืืืืื: ืืืฆื ืืืืืช ืืืชื ืืืืฆืขืืช ืืื ืขืืืง ืืืืืงืืช ืืืขืืื ืืืชืกืืื ืื ืืืืคื ืืื
- ืืื ืืชืคืชืื ืืืืฆืืช ืืืืืื ืืืืช ืืืื ืืจืื ืืจืืืืื ืืืจืืฉืืื
- ืืืืื ืืืกืืกื ืืืืืืฆื โ ืื ืื ืืื ืื ื ืืื. ืื ืขืืื ืขื ืืืืืื ืืื ืื ืืืืืช? ืืืืฆืืืช ืืืืขื ืืชืืื ื ืืืื ืงืื ืืืืจืกืช ืืช ืืืืืืช
- ืืืืืืืืื ืฉื ืืืืืื: ืืคืช ืืขื ืฉื ืืืืื
- ืืฉืื ื ืืื ืืช โ ืกืืจืก ืืืืืืื โ ืื ืื ืื ืืขื ืฉืืกืืืจ ืืฉืื ื ืืื ืืช ืื ืืื ืืืืืช ืืชืจ. ืืื ืื ืืืจืืื ืืืื ืืชืืืืื ืืจืืื ืืกืืืจืื?

ืืชืืืช ืชืืืื